about
Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA...
Read More
2.81
-0.17
(-5.70%)
2.0M
XNAS Volume
XNAS 13 Jul, 2026 11:58 AM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Cabaletta Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..